Avidity Biosciences Ord Shs
RNAM72.860
0.0000.00%
Close 03/03, 16:00（ET）Quotes delayed by 15 min
--Market Cap
--P/E TTM
More Details of Company
Avidity Biosciences Ord Shs Info
Ticker Symbol- -
Company name- -
IPO date- -
CEO- -
Number of employees- -
Security type- -
Fiscal year-end- -
Address- -
City- -
Stock exchange- -
Country- -
Postal code- -
Phone- -
Website- -
Ticker Symbol- -
IPO date- -
CEO- -
Company Executives of Avidity Biosciences Ord Shs
Name
Name/Position
Position
Shareholding
Change
Dr. Troy E. Wilson, J.D., Ph.D.
Dr. Troy E. Wilson, J.D., Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Arthur A. Levin, Ph.D.
Dr. Arthur A. Levin, Ph.D.
Distinguished Scientist and Strategic Leader, Director
Distinguished Scientist and Strategic Leader, Director
--
--
Ms. Sarah Boyce
Ms. Sarah Boyce
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Michael F. (Mike) Maclean
Mr. Michael F. (Mike) Maclean
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Carsten Boess
Mr. Carsten Boess
Independent Director
Independent Director
--
--
Dr. Noreen Roth Henig, M.D.
Dr. Noreen Roth Henig, M.D.
Independent Director
Independent Director
--
--
Dr. Edward M. (Ed) Kaye, M.D.
Dr. Edward M. (Ed) Kaye, M.D.
Independent Director
Independent Director
--
--
Ms. Tamar Thompson
Ms. Tamar Thompson
Independent Director
Independent Director
--
--
Ms. Jean Kim
Ms. Jean Kim
Independent Director
Independent Director
--
--
Dr. W. Michael Flanagan, Ph.D.
Dr. W. Michael Flanagan, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Troy E. Wilson, J.D., Ph.D.
Dr. Troy E. Wilson, J.D., Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Arthur A. Levin, Ph.D.
Dr. Arthur A. Levin, Ph.D.
Distinguished Scientist and Strategic Leader, Director
Distinguished Scientist and Strategic Leader, Director
--
--
Ms. Sarah Boyce
Ms. Sarah Boyce
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Michael F. (Mike) Maclean
Mr. Michael F. (Mike) Maclean
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Carsten Boess
Mr. Carsten Boess
Independent Director
Independent Director
--
--
Dr. Noreen Roth Henig, M.D.
Dr. Noreen Roth Henig, M.D.
Independent Director
Independent Director
--
--
Revenue Breakdown
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2022
FY2021
FY2020
Relevant data have not been disclosed by the company yet.
By RegionUSD
Name
Revenue
Proportion
United States
0.00
0.00%
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Other
100.00%
Shareholders
Shareholders
Proportion
Other
100.00%
Shareholder Types
Shareholders
Proportion
Other
100.00%
Institutional Shareholding
Relevant data have not been disclosed by the company yet.
Reporting Period
No. of institutions
Shares Held
Proportion
Change
No Data
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
No Data
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Splits
Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
